Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | THPO | P40225 | 1/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | MAOA | P21397 | 4/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15702330 | 1.00 | TSHR (0.50) | TSHRCYP3A4CYP2D6NFKB1THPO | |
| SCHEMBL13819753 | 0.87 | — | — | |
| SCHEMBL12773076 | 0.83 | — | — | |
| SCHEMBL12773085 | 0.81 | — | — | |
| SCHEMBL9073207 | 0.79 | TSHR (0.36) | TSHRCYP3A4CYP2D6NFKB1THPO | |
| SCHEMBL3863769 | 0.77 | — | — | |
| SCHEMBL550594 | 0.77 | — | — | |
| SCHEMBL550638 | 0.77 | — | — | |
| SCHEMBL24374520 | 0.77 | SLC7A5 (0.48) | ALDH1A1 | |
| SCHEMBL24359839 | 0.77 | SLC7A5 (0.48) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11718698-B2 | Polyolefin grafted polydiene polymers, and methods of making and using same | BRIDGESTONE CORPORATION (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210230420-A1 | Polyolefin Grafted Polydiene Polymers, And Methods Of Making And Using Same | BRIDGESTONE CORPORATION (JP) | 2021-07-29 | — | — | US | disclosed |
| EP-3397666-B1 | POLYOLEFIN GRAFTED POLYDIENE POLYMERS, AND METHODS OF MAKING AND USING SAME | BRIDGESTONE CORP (JP) | 2020-08-26 | — | — | EP | disclosed |
| CN-108473635-B | Polyolefin grafted polydiene polymers and methods of making and using the same | 株式会社普利司通 | 2020-08-25 | — | — | CN | disclosed |
| EP-3079015-B1 | PHOTOMASK BLANK, RESIST PATTERN FORMING PROCESS, AND METHOD FOR MAKING PHOTOMASK | SHINETSU CHEMICAL CO (JP) | 2020-04-29 | — | — | EP | disclosed |
| US-20180362695-A1 | Polyolefin Grafted Polydiene Polymers, And Methods Of Making And Using Same | BRIDGESTONE CORPORATION (JP) | 2018-12-20 | — | — | US | disclosed |
| US-8647670-B2 | Biocompatible rapid-gelating hydrogel and associated preparation method of spray | BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. (CN) | 2014-02-11 | — | — | US | disclosed |
| US-20100144902-A1 | BIOCOMPATIBLE RAPID-GELATING HYDROGEL AND ASSOCIATED PREPARATION METHOD OF SPRAY | BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD. (CN) | 2010-06-10 | — | — | US | disclosed |
| EP-0966493-A4 | REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS | COMMW SCIENT IND RES ORG (AU) | 2004-04-21 | — | — | EP | disclosed |
| US-6344523-B1 | POLYIMIDES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION OF CAMPBELL (AU) | 2002-02-05 | — | — | US | disclosed |
| EP-0966493-A1 | REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1999-12-29 | — | — | EP | disclosed |
| WO-1998040422-A1 | REDUCED TEMPERATURE CURING OF ACETYLENIC POLYMERS | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1998-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100144902-A1 | BIOCOMPATIBLE RAPID-GELATING HYDROGEL AND ASSOCIATED PREPARATION METHOD OF SPRAY | CSTB, CAPG, F12 | TSHR 1923/4885CYP3A4 1519/4885CYP2D6 2907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.